Company Description
Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. It is a software-as-a-service firm that develops a platform to eliminate technology and information barriers, and simplify investment and operational workflows by un...
Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. It is a software-as-a-service firm that develops a platform to eliminate technology and information barriers, and simplify investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset. The company was founded by Tarek Hammoud, Stephen M. Malherbe, Oleg Movchan, and Scott Werner in 2006 and is headquartered in Chicago, IL.
Valuation
Price to Sales Ratio
21.19
Price to Book Ratio
42.81
Enterprise Value to EBITDA
-3.40
Enterprise Value to Sales
8.28
Efficiency
Total Asset Turnover
1.54
Liquidity
Current Ratio
11.06
Quick Ratio
11.06
Cash Ratio
7.94
Profitability
Gross Margin
71.49
Operating Margin
-246.99
Pretax Margin
-252.16
Net Margin
-141.73
Return on Assets
-218.09
Return on Total Capital
-431.20
Capital Structure
Officers and Executives
Name | Age | Officer Since | Title |
---|---|---|---|
Mr. Stephen P. Dorton | 55 | 2019 | Chief Financial Officer |
Mr. Xin Wei Wang | - | 2021 | Chief Strategy Officer |
Insider Actions
05/11/2022 |
Oleg Movchan Director |
1,401,818 | Derivative/Non-derivative trans. at $0 per share. | 0 |
10/31/2021 |
Lawrence E. Leibowitz Director |
5,515 | Award at $0 per share. | 0 |
10/31/2021 |
Kathleen Traynor DeRose Director |
5,515 | Award at $0 per share. | 0 |
10/31/2021 |
Kathleen Traynor DeRose Director |
11,029 | Award at $0 per share. | 0 |
10/31/2021 |
Jan R. Hauser Director |
5,515 | Award at $0 per share. | 0 |
10/31/2021 |
Jan R. Hauser Director |
11,029 | Award at $0 per share. | 0 |
10/25/2021 |
Financial Technology Ventures Management Co. LLC Director |
4,075,531 | Disposition at $15.9 per share. | 64,800,942 |
10/25/2021 |
HHLR Advisors Ltd. |
647,862 | Disposition at $15.9 per share. | 10,301,005 |
10/25/2021 |
Iconiq Capital LLC Director |
722,707 | Acquisition at $17 per share. | 12,286,019 |
10/25/2021 |
Iconiq Capital LLC Director |
538,887 | Acquisition at $17 per share. | 9,161,079 |
MarketWatch News on ENFN
-
Enfusion stock price target cut to $20 vs. $27 at Stifel
- Ciara Linnane
-
Enfusion started at buy with $27 stock price target at Stifel Nicolaus
- Tomi Kilgore
-
Enfusion stock opens at $20, or about 18% above $17 IPO price
- Tomi Kilgore
-
Enfusion sets IPO terms, to raise up to $260.5 mln
- Tomi Kilgore
Other News on ENFN
-
Top 5 1st Quarter Trades of Ararat Capital Management, LP
- GuruFocus.com
-
AMRS and LLL among mid-day movers
- Seeking Alpha
-
Are Tech And Growth Stocks Dead? Far From It
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
Tech And Growth Stocks: Positioning Your Portfolios For Q2 2022
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
Why Enfusion Stock Is Plummeting Today
- Motley Fool
-
DLNG, MULN and OCFT among mid-day movers
- Seeking Alpha
-
Hhlr Advisors, Ltd. Buys Sea, Salesforce. ...
- GuruFocus.com
- Loading more headlines...